Westport, CT, June 04, 2020 (GLOBE NEWSWIRE) — BioSig Applied sciences, Inc. (NASDAQ: BSGM) (“BioSig” or the “Firm”), a medical expertise firm commercializing a proprietary biomedical sign processing platform designed to enhance sign constancy and uncover the total vary of ECG and intra-cardiac indicators, at present introduced that two scientific classes highlighting PURE EP(tm) System have been accepted into Coronary heart Rhythm Society 2020 Science.
The 2 half set of movies titled ‘Cardiac Sign Acquisition and Scientific Issues for Correct Interpretation’ might be introduced throughout the HRS Rhythm Theater Classes on June 12 and July 1, 2020. The classes will cowl the challenges of buying clear indicators within the EP lab atmosphere, foundational ideas of cardiac sign acquisition and scientific implications of making use of filters to cardiac indicators. The content material of the collection might be complemented by the scientific examples acquired by PURE EP(tm) System. The collection might be introduced by Samuel J. Asirvatham, M.D., Cardiac Electrophysiologist, Professor of Medication at Mayo Clinic Rochester, MN and Okay.L. Venkatachalam, BSEE, M.D., Cardiac Electrophysiologist, Affiliate Professor of Medication at Mayo Clinic’s Florida campus.
“The annual Coronary heart Rhythm Society conventions are the highlights in our business calendars, and we’re happy that the HRS committee is bringing the electrophysiology neighborhood collectively by way of its digital scientific classes this summer season,” commented Kenneth L. Londoner, Chairman and CEO of BioSig Applied sciences, Inc. “BioSig has been busy searching for to generate huge quantities of scientific knowledge and initiating new installations, and we’re significantly grateful to Drs. Asirvatham and Venkatachalam for his or her dedication to innovation and their ongoing assist of our scientific efforts.”
About Coronary heart Rhythm Society’s Scientific Classes
The Coronary heart Rhythm Society’s Annual Scientific Classes is a Coronary heart Rhythm Society program. Coronary heart Rhythm Society (HRS) is a 501c3 worldwide nonprofit group with a mission to enhance the care of sufferers by selling analysis, schooling, and optimum well being care insurance policies and requirements. Based in 1979, HRS is a number one useful resource on cardiac pacing and electrophysiology. This specialty group represents medical, allied well being, and science professionals from greater than 70 international locations who concentrate on cardiac rhythm issues.
About BioSig Applied sciences
BioSig Applied sciences is a medical expertise firm commercializing a proprietary biomedical sign processing platform designed to enhance sign constancy and uncover the total vary of ECG and intra-cardiac indicators (www.biosig.com).
The Firm’s first product, PURE EP(tm) System is a computerized system meant for buying, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac indicators for sufferers present process electrophysiology (EP) procedures in an EP laboratory.
This press launch accommodates “forward-looking statements.” Such statements could also be preceded by the phrases “intends,” “might,” “will,” “plans,” “expects,” “anticipates,” “tasks,” “predicts,” “estimates,” “goals,” “believes,” “hopes,” “potential” or related phrases. Ahead- wanting statements should not ensures of future efficiency, are based mostly on sure assumptions and are topic to varied identified and unknown dangers and uncertainties, a lot of that are past the Firm’s management, and can’t be predicted or quantified and consequently, precise outcomes might differ materially from these expressed or implied by such forward-looking statements. Such dangers and uncertainties embrace, with out limitation, dangers and uncertainties related to (i) the geographic, social and financial influence of COVID-19 on our potential to conduct our enterprise and lift capital sooner or later when wanted, (ii) our lack of ability to fabricate our merchandise and product candidates on a business scale on our personal, or in collaboration with third events; (iii) difficulties in acquiring financing on commercially affordable phrases; (iv) adjustments within the measurement and nature of our competitors; (v) lack of a number of key executives or scientists; and (vi) difficulties in securing regulatory approval to market our merchandise and product candidates. Extra detailed details about the Firm and the danger elements that will have an effect on the belief of forward-looking statements is ready forth within the Firm’s filings with the Securities and Alternate Fee (SEC), together with the Firm’s Annual Report on Kind 10-Okay and its Quarterly Studies on Kind 10-Q. Traders and safety holders are urged to learn these paperwork freed from cost on the SEC’s web site at http://www.sec.gov. The Firm assumes no obligation to publicly replace or revise its forward-looking statements on account of new info, future occasions or in any other case.
Andrew Ballou BioSig Applied sciences, Inc. Vice President, Investor Relations 54 Wilton Street, 2nd flooring Westport, CT 06880 firstname.lastname@example.org 203-409-5444, x133